• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期心力衰竭:从定义到治疗选择。

Advanced heart failure: from definitions to therapeutic options.

作者信息

Garascia Andrea, Palazzini Matteo, Tedeschi Andrea, Sacco Alice, Oliva Fabrizio, Gentile Piero

机构信息

De Gasperis Cardio Center, Ospedale Niguarda, Piazza Ospedale Maggiore 3, Milano, Italia.

出版信息

Eur Heart J Suppl. 2023 Apr 26;25(Suppl C):C283-C291. doi: 10.1093/eurheartjsupp/suad028. eCollection 2023 May.

DOI:10.1093/eurheartjsupp/suad028
PMID:37125285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10132575/
Abstract

Advanced heart failure (AHF) represents an ominous stage of heart failure (HF), where the expected prognosis remains poor regardless of the improvement in medical knowledge. In this review, we summarize the definition, prognosis, physiopathology, and clinical/therapeutic management of the disease, focusing on the fast and timely referral of the patient to the AHF facilities. We provide an insight of the diagnostic and therapeutic 'work up' performed in an Italian AHF hub, implying a deep phenotypical patients characterization in order to evaluate candidacy to the therapeutic gold standards as heart transplantation (HTx) and left ventricular assist device (LVAD).

摘要

晚期心力衰竭(AHF)是心力衰竭(HF)的一个凶险阶段,无论医学知识如何进步,其预期预后仍然很差。在本综述中,我们总结了该疾病的定义、预后、生理病理学以及临床/治疗管理,重点关注患者快速及时转诊至AHF治疗机构。我们深入了解了意大利一个AHF中心所进行的诊断和治疗“评估”,这意味着要对患者进行深入的表型特征分析,以便评估其接受心脏移植(HTx)和左心室辅助装置(LVAD)等治疗金标准的候选资格。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b1/10132575/401c30a15424/suad028f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b1/10132575/9f36f90510d6/suad028f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b1/10132575/401c30a15424/suad028f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b1/10132575/9f36f90510d6/suad028f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b1/10132575/401c30a15424/suad028f2.jpg

相似文献

1
Advanced heart failure: from definitions to therapeutic options.晚期心力衰竭:从定义到治疗选择。
Eur Heart J Suppl. 2023 Apr 26;25(Suppl C):C283-C291. doi: 10.1093/eurheartjsupp/suad028. eCollection 2023 May.
2
Outcomes of COVID-19 in heart failure, LVAD, and heart transplant patients in an advanced heart failure practice.晚期心力衰竭治疗中,心力衰竭、左心室辅助装置及心脏移植患者的新型冠状病毒肺炎结局
Am Heart J Plus. 2022 Dec;24:100223. doi: 10.1016/j.ahjo.2022.100223. Epub 2022 Nov 3.
3
A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.接受高龄供体心脏移植患者与接受左心室辅助装置植入患者中期结局的前瞻性比较。
Interact Cardiovasc Thorac Surg. 2016 Oct;23(4):584-92. doi: 10.1093/icvts/ivw164. Epub 2016 May 30.
4
Quality of life of advanced chronic heart failure: medical care, mechanical circulatory support and transplantation.晚期慢性心力衰竭的生活质量:医疗护理、机械循环支持与移植
Eur J Cardiothorac Surg. 2016 Aug;50(2):269-73. doi: 10.1093/ejcts/ezw054. Epub 2016 Apr 22.
5
Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.持续血流左心室辅助装置与心脏移植后的中期生存率
Heart Vessels. 2016 May;31(5):722-33. doi: 10.1007/s00380-015-0654-4. Epub 2015 Mar 4.
6
Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation.半乳糖凝集素-3在晚期心力衰竭患者中、左心室辅助装置支持期间及心脏移植后的动态变化及预后作用
BMC Cardiovasc Disord. 2016 Jun 14;16:138. doi: 10.1186/s12872-016-0298-z.
7
Duration of Heart Failure Is an Important Predictor of Outcomes After Mechanical Circulatory Support.心力衰竭的持续时间是机械循环支持后预后的重要预测指标。
Circ Heart Fail. 2015 Sep;8(5):953-9. doi: 10.1161/CIRCHEARTFAILURE.115.002321. Epub 2015 Aug 6.
8
Randomized trial of a left ventricular assist device as destination therapy versus guideline-directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trial.随机试验:左心室辅助装置作为终末期心力衰竭患者的治疗目标与指南指导的药物治疗的比较。SWEdish evaluation of left Ventricular Assist Device(SweVAD)试验的原理和设计。
Eur J Heart Fail. 2020 Apr;22(4):739-750. doi: 10.1002/ejhf.1773. Epub 2020 Feb 26.
9
Copeptin in Heart Failure, Post-Left Ventricular Assist Device and Post-Heart Transplantation.心力衰竭、左心室辅助装置植入后及心脏移植后的 copeptin(copeptin 是一种由精氨酸加压素原基因编码的含 39 个氨基酸的肽段,中文一般译为“ copeptin”,暂未找到更合适的中文名,你可根据实际情况修改)
Heart Lung Circ. 2017 Feb;26(2):143-149. doi: 10.1016/j.hlc.2016.05.119. Epub 2016 Jul 14.
10
Discordant Perceptions of Prognosis and Treatment Options Between Physicians and Patients With Advanced Heart Failure.医生和晚期心力衰竭患者对预后和治疗选择的看法存在差异。
JACC Heart Fail. 2017 Sep;5(9):663-671. doi: 10.1016/j.jchf.2017.04.009. Epub 2017 Aug 16.

引用本文的文献

1
Addressing Endothelial Dysfunction in Heart Failure: The Role of Endothelial Progenitor Cells and New Treatment Horizons.解决心力衰竭中的内皮功能障碍:内皮祖细胞的作用及新的治疗前景。
Card Fail Rev. 2025 Aug 18;11:e21. doi: 10.15420/cfr.2025.02. eCollection 2025.
2
Transition to Advanced Heart Failure: From Identification to Improving Prognosis.向晚期心力衰竭的转变:从识别到改善预后
J Cardiovasc Dev Dis. 2025 Mar 17;12(3):104. doi: 10.3390/jcdd12030104.
3
Cost Effectiveness of Left Ventricular Assist Devices (LVADs) as Destination Therapy: A Systematic Review.

本文引用的文献

1
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.乙酰唑胺治疗急性失代偿性心力衰竭伴容量超负荷
N Engl J Med. 2022 Sep 29;387(13):1185-1195. doi: 10.1056/NEJMoa2203094. Epub 2022 Aug 27.
2
Genetically Modified Porcine-to-Human Cardiac Xenotransplantation.基因编辑猪-人心脏异种移植。
N Engl J Med. 2022 Jul 7;387(1):35-44. doi: 10.1056/NEJMoa2201422. Epub 2022 Jun 22.
3
Haemodynamic effects of sacubitril/valsartan in advanced heart failure.沙库巴曲缬沙坦对晚期心力衰竭的血液动力学影响。
作为终末期治疗的左心室辅助装置(LVADs)的成本效益:一项系统评价。
Pharmacoecon Open. 2025 May;9(3):351-363. doi: 10.1007/s41669-025-00564-4. Epub 2025 Feb 20.
4
Transcatheter aortic valve replacement for left ventricular assist device-related aortic regurgitation and prohibitive surgical risk: a case report.经导管主动脉瓣置换术治疗左心室辅助装置相关的主动脉瓣反流及手术风险极高:一例病例报告
Eur Heart J Case Rep. 2025 Jan 23;9(2):ytaf027. doi: 10.1093/ehjcr/ytaf027. eCollection 2025 Feb.
5
Heart Failure Management through Telehealth: Expanding Care and Connecting Hearts.通过远程医疗进行心力衰竭管理:扩大护理范围并连接心灵。
J Clin Med. 2024 Apr 28;13(9):2592. doi: 10.3390/jcm13092592.
6
Latest updates on structure and recommendations of cardiac rehabilitation programs in chronic heart failure.慢性心力衰竭心脏康复计划的结构与建议的最新进展
World J Clin Cases. 2024 Mar 16;12(8):1382-1387. doi: 10.12998/wjcc.v12.i8.1382.
ESC Heart Fail. 2022 Apr;9(2):894-904. doi: 10.1002/ehf2.13755. Epub 2022 Jan 22.
4
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
5
Advanced Heart Failure Epidemiology and Outcomes: A Population-Based Study.心力衰竭的流行病学和预后:基于人群的研究。
JACC Heart Fail. 2021 Oct;9(10):722-732. doi: 10.1016/j.jchf.2021.05.009. Epub 2021 Aug 11.
6
Long-term administration of intravenous inotropes in advanced heart failure.长期静脉内正性肌力药物治疗晚期心力衰竭。
ESC Heart Fail. 2021 Oct;8(5):4322-4327. doi: 10.1002/ehf2.13394. Epub 2021 Jun 30.
7
Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction.恩格列净对射血分数降低的心力衰竭患者血液动力学的影响。
J Am Coll Cardiol. 2020 Dec 8;76(23):2740-2751. doi: 10.1016/j.jacc.2020.10.005.
8
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.肌球蛋白激活治疗收缩性心力衰竭的奥马曲珠单抗
N Engl J Med. 2021 Jan 14;384(2):105-116. doi: 10.1056/NEJMoa2025797. Epub 2020 Nov 13.
9
Cardiac output improvement by pecavaptan: a novel dual-acting vasopressin V1a/V2 receptor antagonist in experimental heart failure.培维索坦改善心输出量:一种新型双重作用血管加压素 V1a/V2 受体拮抗剂在实验性心力衰竭中的作用。
Eur J Heart Fail. 2021 May;23(5):743-750. doi: 10.1002/ejhf.2001. Epub 2020 Oct 9.
10
Evaluation for Heart Transplantation and LVAD Implantation: JACC Council Perspectives.心脏移植与左心室辅助装置植入的评估:美国心脏病学会理事会观点。
J Am Coll Cardiol. 2020 Mar 31;75(12):1471-1487. doi: 10.1016/j.jacc.2020.01.034.